Science 37 Holdings, Inc. – NASDAQ:SNCE
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Science 37 Holdings stock price monthly change
-3.88%
month
Science 37 Holdings stock price quarterly change
+1883.30%
quarter
Science 37 Holdings stock price yearly change
+1256.82%
year
Science 37 Holdings key metrics
Market Cap | 34.66M |
Enterprise value | N/A |
P/E | -0.6 |
EV/Sales | -1.03 |
EV/EBITDA | 2.87 |
Price/Sales | 0.49 |
Price/Book | 0.35 |
PEG ratio | N/A |
EPS | -1.06 |
Revenue | 60.26M |
EBITDA | 13.77M |
Income | -123.53M |
Revenue Q/Q | -8.38% |
Revenue Y/Y | -19.20% |
Profit margin | -72.69% |
Oper. margin | -216.74% |
Gross margin | 22.62% |
EBIT margin | -216.74% |
EBITDA margin | 22.86% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeScience 37 Holdings stock price history
Science 37 Holdings stock forecast
Science 37 Holdings financial statements
| Dec 2022 | 15.93M | -66.52M | -417.43% |
|---|---|---|---|
| Mar 2023 | 14.08M | -23.50M | -166.89% |
| Jun 2023 | 15.35M | -19.57M | -127.54% |
| Sep 2023 | 14.88M | -13.92M | -93.53% |
| Jun 2023 | 15.35M | -19.57M | -127.54% |
|---|---|---|---|
| Sep 2023 | 14.88M | -13.92M | -93.53% |
| Sep 2025 | 22.70M | -23.62M | -104.06% |
| Dec 2025 | 24.21M | -23.62M | -97.56% |
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 126448000 | 29.06M | 22.98% |
|---|---|---|---|
| Mar 2023 | 101446000 | 23.33M | 23% |
| Jun 2023 | 86956000 | 24.70M | 28.42% |
| Sep 2023 | 75727000 | 23.98M | 31.67% |
| Dec 2022 | -15.06M | -7.08M | -62K |
|---|---|---|---|
| Mar 2023 | -19.61M | -5.94M | 87K |
| Jun 2023 | -13.11M | -4.54M | -3K |
| Sep 2023 | -400K | -7.92M | -240K |
Science 37 Holdings alternative data
| Aug 2023 | 460 |
|---|---|
| Sep 2023 | 460 |
| Oct 2023 | 460 |
| Nov 2023 | 460 |
| Dec 2023 | 460 |
| Jan 2024 | 460 |
| Feb 2024 | 460 |
| Mar 2024 | 460 |
| Apr 2024 | 460 |
| May 2024 | 460 |
| Jun 2024 | 460 |
| Jul 2024 | 460 |
Science 37 Holdings other data
16.08%
-32.63%
of SNCE is owned by hedge funds
33
-28
18.63M
-38.07M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2022 | 5000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | SHIPTON MICHAEL officer: Chief Commercial Officer | Restricted Stock Units | 100,000 | N/A | N/A | ||
Option | SHIPTON MICHAEL officer: Chief Commercial Officer | Common Stock | 100,000 | N/A | N/A | ||
Option | COMAN DAVID officer: Chief Ex.. | Common Stock | 495,122 | N/A | N/A | ||
Option | COMAN DAVID officer: Chief Ex.. | Restricted Stock Units | 495,122 | N/A | N/A | ||
Option | FORMAN DARCY officer: Chief Delivery Officer | Common Stock | 288,972 | N/A | N/A | ||
Option | FORMAN DARCY officer: Chief Delivery Officer | Restricted Stock Units | 288,972 | N/A | N/A | ||
Option | ZARANEK MIKE officer: Chief Financial Officer | Common Stock | 256,207 | N/A | N/A | ||
Option | COTLIAR JONATHAN officer: Chief Me.. | Common Stock | 230,882 | N/A | N/A | ||
Option | ZARANEK MIKE officer: Chief Financial Officer | Restricted Stock Units | 256,207 | N/A | N/A | ||
Option | COTLIAR JONATHAN officer: Chief Me.. | Restricted Stock Units | 230,882 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 15 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 6 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. David Coman (1969) Chief Executive Officer & Director | $661,220 |
| Mr. Steven Geffon (1978) Chief Commercial Officer | $569,350 |
| Mr. Jonathan Cotliar (1971) Chief Medical Officer | $486,600 |
-
When is Science 37 Holdings's next earnings date?
Unfortunately, Science 37 Holdings's (SNCE) next earnings date is currently unknown.
-
Does Science 37 Holdings pay dividends?
No, Science 37 Holdings does not pay dividends.
-
How much money does Science 37 Holdings make?
Science 37 Holdings has a market capitalization of 34.66M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.7% to 70.15M US dollars.
-
What is Science 37 Holdings's stock symbol?
Science 37 Holdings, Inc. is traded on the NASDAQ under the ticker symbol "SNCE".
-
What is Science 37 Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Science 37 Holdings?
Shares of Science 37 Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Science 37 Holdings's key executives?
Science 37 Holdings's management team includes the following people:
- Mr. David Coman Chief Executive Officer & Director(age: 56, pay: $661,220)
- Mr. Steven Geffon Chief Commercial Officer(age: 47, pay: $569,350)
- Mr. Jonathan Cotliar Chief Medical Officer(age: 54, pay: $486,600)
-
How many employees does Science 37 Holdings have?
As Jul 2024, Science 37 Holdings employs 460 workers.
-
When Science 37 Holdings went public?
Science 37 Holdings, Inc. is publicly traded company for more then 4 years since IPO on 23 Nov 2020.
-
What is Science 37 Holdings's official website?
The official website for Science 37 Holdings is science37.com.
-
Where are Science 37 Holdings's headquarters?
Science 37 Holdings is headquartered at 800 Park Offices Drive, Research Triangle Park, NC.
-
How can i contact Science 37 Holdings?
Science 37 Holdings's mailing address is 800 Park Offices Drive, Research Triangle Park, NC and company can be reached via phone at +98 43773737.
Science 37 Holdings company profile:
Science 37 Holdings, Inc.
science37.comExchange:
NASDAQ
Full time employees:
460
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
800 Park Offices Drive
Research Triangle Park, NC 27709
Research Triangle Park, NC 27709
CIK: 0001819113
ISIN: US8086442071
CUSIP: 808644108
